Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Melissa Bersanelli

Adjunct Professor in Medical Oncology

University of Parma

Italy

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacotherapy

50%

Immunology

80%

Immunotherapy

40%

Adjuvant Therapy

40%

Cancer Therapy

30%

Cancer Biology

30%

Oncology

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles11

Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity

Article Link

Year:

2023

Validation of a drug-based score in advanced urothelial carcinoma treated with pembrolizumab

Article Link

Year:

2023

Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer

Article Link

Year:

2023

Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup

Article Link

Year:

2023

Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational study

Article Link

Year:

2023

Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a)

Article Link

Year:

2023

Immune checkpoint inhibitors in non-conventional histologies of renal-cell carcinoma

Article Link

Year:

2023

Characterization of Age-Associated, Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammatory Index (SII) as Biomarkers of Inflammation in Geriatric Patients with Cancer Treated with Immune Checkpoint Inhibitors: Impact on Efficacy and Survival

Article Link

Year:

2023

Antibiotic-dependent effect of probiotics in patients with non-small cell lung cancer treated with PD-1 checkpoint blockade

Article Link

Year:

2022

Immune checkpoint inhibitors in adjuvant setting after radical resection of melanoma: a meta-analysis of the pivotal trials

Article Link

Year:

2022

Validation of a Novel Three-Dimensional (<i>3D Fusion</i>) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study

Article Link

Year:

2022

Collaborators20

Ludimila Cavalcante

Associate Professor, Director, Sarcoma Medical Oncology, Associate Director, Developmental Therapeutics

University of Virginia

UNITED STATES

Maurizio Colecchia

Professor

Università Vita Salute San Raffaele

ITALY

Marco Gaetano Tucci

Assistant Professor

University of Bari

ITALY

Bruno Vincenzi

Professor of Medical Oncology

Università Campus Bio-Medico

ITALY

Umberto Basso

Consultant Medical Oncologist, Full Time. Chief of Genito-Urinary Program

Istituto Oncologico Veneto IOV-IRCCS

ITALY

Giorgio Malpeli

Professor

Link Campus University

ITALY

Kazuma Sugimoto

University of Tokyo Hospital

JAPAN

Sebastiano Buti

ITALY

maria rosaria raspollini

University of Florence

ITALY

Yukari Uemura

Section Chief

National Center For Global Health and Medicine

JAPAN

Andrea Cossarizza

Full Professor of Pathology and Immunology

University of Modena and Reggio Emilia

ITALY

Valerio Gaetano Vellone

University of Genoa

ITALY

Maria Giuseppa Vitale

ITALY

Filippo Alongi

University of Brescia

ITALY

Taketo Kawai

Teikyo University School of Medicine

JAPAN

Stefano Gobbo

Professore Associato

University of Ferrara

ITALY

Holger Moch

Professor

University of Zurich

SWITZERLAND

Luisa Barzon

Associate Professor

University of Padova

ITALY

Yinghong Wang

The University of Texas MD Anderson Cancer Center

UNITED STATES

Antonio D'Alessio

Imperial College London

UNITED KINGDOM

How do I reach out?

Meet Kite AI